Alkem Laboratories Limited (NSE:ALKEM)
5,400.00
0.00 (0.00%)
Aug 21, 2026, 3:14 PM IST
Alkem Laboratories Revenue
Alkem Laboratories had revenue of 37.40B INR in the quarter ending June 30, 2026, with 10.95% growth. This brings the company's revenue in the last twelve months to 150.81B, up 13.36% year-over-year. In the fiscal year ending March 31, 2026, Alkem Laboratories had annual revenue of 147.12B with 13.48% growth.
Revenue (ttm)
150.81B
Revenue Growth
+13.36%
P/S Ratio
4.28
Revenue / Employee
7.80M
Employees
19,346
Market Cap
645.65B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 147.12B | 17.48B | 13.48% |
| Mar 31, 2025 | 129.65B | 2.97B | 2.34% |
| Mar 31, 2024 | 126.68B | 10.68B | 9.21% |
| Mar 31, 2023 | 115.99B | 9.65B | 9.08% |
| Mar 31, 2022 | 106.34B | 17.69B | 19.96% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aurobindo Pharma | 349.35B |
| Zydus Lifesciences | 285.92B |
| Cipla | 280.68B |
| Glenmark Pharmaceuticals | 177.37B |
| Mankind Pharma | 147.38B |
| Ipca Laboratories | 101.26B |
| Emcure Pharmaceuticals | 96.83B |
| Laurus Labs | 72.70B |
Alkem Laboratories News
- 8 days ago - Alkem Laboratories Transcript: Q1 26/27 - Transcripts
- 8 days ago - Alkem Laboratories Quarterly report: Q1 2027 - Filings
- 8 days ago - Alkem Laboratories Slides: Q1 2027 - Filings
- 9 days ago - Earnings To Watch: Alkem Laboratories Ltd (NSE:ALKEM) Q1 2027 -- GF Value Sees 26% Upside - GuruFocus
- 7 weeks ago - Alkem Medtech executes supplementary agreement for Occlutech acquisition - Business Upturn
- 2 months ago - Alkem Laboratories launches semaglutide pre-filled syringes in India starting at Rs 350 - Business Upturn
- 3 months ago - Alkem Laboratories shares rally over 6% after Q4 results; Revenue and EBITDA growth support sentiment - Business Upturn
- 3 months ago - Ashok Leyland, Wipro, Alkem Labs, Finolex Cables, Delta Corp, BDL, Zydus Life, HBL Engineering, Apar Industries, Indostar shares in focus today, May 29 - Business Upturn